about
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrastOutcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazoleRisk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisTB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysisClinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnessesHypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesAltered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory SyndromeComplications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosisCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaTuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settingsA dimorphic fungus causing disseminated infection in South Africa.A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection.Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional studyEarly severe morbidity and resource utilization in South African adults on antiretroviral therapy.Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected casesClinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis.Utility of Second-Generation Line Probe Assay (Hain MTBDRplus) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response.Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort StudyTB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasoneAntiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral TherapyOptimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections.High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll outTesting but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting.Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis.Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study.Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.AIDS-related mycoses: the way forward.Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndromeIndependent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsDissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeAssessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients.Failure to eradicate Isospora belli diarrhoea despite immune reconstitution in adults with HIV--a case series.
P50
Q24620256-37C566F3-780B-4EF9-A2A6-65DA4E7A40A2Q24678763-2381AF79-00B0-4ACA-9E3C-24159933668BQ26781111-FB988868-3042-44B8-A2A6-738D57AA8365Q28073480-31513963-23BE-490B-A7FC-DDBA046FF5A3Q28474814-BEC2543E-E71C-4C7A-982D-5A16E6979AB9Q28476626-C34CA959-F9C3-4372-A7A9-A0D4145ABF90Q28484347-574B2039-26E2-451A-967D-7F1DCCC4711EQ28486096-3D390A8E-6685-43F6-B103-BFAB2CF7D725Q28534733-4DD41866-923D-422C-B968-43CFA0EBBBA2Q28749315-4E02DF50-F5D2-49C3-B896-B4C7587CF8F4Q30672930-9BBFB25F-6DD7-4806-B62B-295EC6B23CC1Q30844823-90AF6C23-F549-40B7-A7A0-9B28AFD81F78Q33337508-B4BFF0BE-9E43-440D-93BB-89A4DB69DBA8Q33518021-54E70770-5B98-412B-993F-CF2C48556A87Q33540873-FF0E7B7D-3602-4D9E-ACE7-D4AFE0347862Q33547682-AD535752-205A-4CF4-B168-8D6D01134051Q33553788-BBB21BFE-3088-4868-BD16-C9CE6F37A1B0Q33603890-7D3B5B9D-C0FA-40FA-AF9E-083AA31FF84CQ33621748-55B69BF7-48E8-4C37-917B-5EABF8DC13C5Q33712746-8B8282C1-48A3-46A1-B851-94BD9213D91DQ33732480-98AB793B-BD34-459C-A049-5AFD22BDA16FQ33783987-5897125C-6930-47B3-B069-5510C32D12ADQ33793447-CCB0AF15-F1E0-41FF-AC0D-32763DC7F1A0Q33823233-1C7BA1B8-FFCB-4A56-896B-EA6848F982ABQ33854516-7CBD5AFB-32C5-48AB-853B-D338D635707EQ33858110-39D58B38-4A10-4BD2-8AD2-D6A621563305Q33888707-44757B2A-84C2-4402-97D7-FDAA381448F3Q33903941-86A1AA53-5727-4ED5-B93C-438E1FAB75B0Q33916426-9BA6E57B-4233-4759-88B4-DB9FBA669805Q33953918-EDECD509-0A3F-4DB3-8CED-F8294DBBF7FDQ33968248-FD513D85-1A19-4BE3-BCA1-1FAF3EE4813DQ34024416-BE9197B3-37D8-4764-9DC2-9A1D44DFE828Q34030928-7690C103-E52D-45BE-A543-E7FEE10CDB12Q34130659-CF68E6A9-04A6-47B8-BFCE-14266575724EQ34247688-4A558E17-5ACC-454F-B532-17776B5C9D10Q34251506-0E06CF7E-652D-4293-A26E-181D87F22D0AQ34255402-0D2E44D7-5297-408B-8D72-F8DF0A207D7EQ34282914-BF60697F-654A-42FB-8042-23C76722A91CQ34311748-7A0FBD57-2A68-4197-8170-E416585220E0Q34374785-3DA14C58-9B88-4C40-89F4-B08C57B421EF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Graeme Meintjes
@ast
Graeme Meintjes
@en
Graeme Meintjes
@es
Graeme Meintjes
@nl
Graeme Meintjes
@sl
type
label
Graeme Meintjes
@ast
Graeme Meintjes
@en
Graeme Meintjes
@es
Graeme Meintjes
@nl
Graeme Meintjes
@sl
prefLabel
Graeme Meintjes
@ast
Graeme Meintjes
@en
Graeme Meintjes
@es
Graeme Meintjes
@nl
Graeme Meintjes
@sl
P106
P21
P31
P496
0000-0003-1196-4414